Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

InMed Pharmaceuticals Inc. INM

Full chart Compare
Set alert

Price alert · INM

All alert types
15.56 USD +2.55 (+19.65%)

At closeNov 6, 2026, 4:00 PM EST

14.58 -0.98 -6.30%

After hours · Nov 6, 4:00 PM ET

13.70 Day range 16.44
5.75 52-week range 23.30
YTD
+46.79%
1 year
-8.74%

Revenue & Expenses

Other Operating Income → Expenses: $1.89BExpenses → Selling, General & Admin: $1.88BExpenses → Research & Development: $15.13MExpenses → Other Expenses: $713.21MGross Profit → Expenses: $709.84MRevenue → Gross Profit: $709.84MRevenue → Cost of Revenue: $2.47BNet Loss → Expenses: $12.56MOther Operating Income$1.89BGross Profit$709.84MNet Loss$12.56MCost of Revenue$2.47BExpenses$2.61BSelling, General & Admin$1.88BResearch & Development$15.13MOther Expenses$713.21MRevenue$3.18B

Latest period ending Jun 30, 2026 · select a line to chart its full history

Income statement

Full income statement How to read it
INM annual income statement
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022
-11.55M-8.45M-8.13M-8.38M-17.26M
-12.56M-8.16M-7.68M-7.95M-18.60M
-31.20-84.00-201.00-650.00-6,634.00

Balance sheet

Full balance sheet How to read it
INM annual balance sheet
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022
2.19M10.74M6.57M8.91M6.18M
3.03M15.58M11.82M14.11M12.79M
1.96M2.15M2.62M2.02M3.71M
1.08M13.43M9.21M12.09M9.08M

Cash flow

Full cash flow How to read it
INM annual cash flow
Fiscal yearFY 2026 Jun 30, 2026FY 2025 Jun 30, 2025FY 2024 Jun 30, 2024FY 2023 Jun 30, 2023FY 2022 Jun 30, 2022
-8.64M-8.10M-6.99M-7.28M-15.58M
94.50K12.27M4.65M10.68M15.07M
-8.55M4.17M-2.34M2.74M-1.19M